Table 1.
Criteria for appropriate vancomycin use according to the CDC criteria [4]
| Appropriate use |
| Serious infections caused by b-lactam-resistant Gram-positive microorganisms; |
| Infection caused by Gram-positive organisms in patients allergic to b-lactam antimicrobials; |
| Antibiotics treatment for colitis when there is a problem with metronidazole use or imminent life risk; |
| Surgical prophylaxis, with prosthesis implant, in institutions with high rates of oxacillin-resistant Gram-positive infections; |
| Neutropenics with extensive mucosite, infection related to venous catheters, previous prophylaxis with fluorquinolone, hypotension or sepsis. |
| Inappropriate use: |
| Routine surgical prophylaxis; |
| Febrile neutropenia that does not present isolation of oxacillin-resistant Gram-positive bacteria; |
| Treatment of a single blood culture for oxacillin-resistant Staphylococcus, coagulase-negative, if another culture collected simultaneously was sterile; |
| Empirical use, continuous, in patients whose cultures are negative for Gram-positive bacteria; |
| Presence of catheter and fever; |
| Decontamination of the gastrointestinal tract; |
| Prophylaxis for low birth weight infants; |
| Primary treatment of colitis by antibiotics; |
| Colonization by oxacillin-resistant Gram-positive bacteria; |
| Prophylaxis for patients in continuous peritoneal dialysis or hemodialysis; |
| Convenience treatment of infections by b-lactam-sensitive Gram-positive in hemodialysis patients; |
| Topical vancomycin use. |